TNFRSF17 and plasma cell myeloma: Although the M protein in the peripheral blood of Ptwith 6 disappeared after treatment, as did myeloma cells in the BM, he did not achieve sCR/CR as of the cutoff date because he had extramedullary lesions that did not disappear after humanized anti-BCMA CAR T cell therapy.